FISCAL 2025 Q4 HIGHLIGHTS Net sales of $978.2 million increased 2.7% YoY Operating income of $84.3 million, or $90.3 million on an adjusted basis1 Operating margin of 8.6%, or 9.2% on an adjusted ...

X4 Pharmaceuticals (Nasdaq: XFOR) (“X4” or the “Company”), a company driven to improve the lives of people with rare ...

Wealthsimple, Canada's leading financial innovator, today announced it has signed an equity round of up to CAD $750 million ...

New York, NY, USA, October 27th, 2025, FinanceWireYanne Capital formalizes a senior-led, relationship-driven investment ...

Alliance Resource Partners, L.P. ("ARLP" or the "Partnership") today reported financial and operating results for the three and nine months ended September 30, 2025 (the "2025 Quarter" and "2025 ...

This news release constitutes a “designated news release” for the purposes of the Company’s amended and restated prospectus supplement dated May 14, 2025, to its short form base shelf prospectus ...

Avidity Biosciences, Inc. ("Avidity") (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA ...

Revenue of $4.1 billion, an increase of 2% with organic growth of 1%Record operating margin of 27.4%, an expansion of 90 bps as enterprise initiatives contributed 140 bpsGAAP EPS of $2.81, an increase ...

Third Quarter 2025 Results Third quarter revenue of $4.1 billion increased by two percent as organic revenue grew one percent. Foreign currency translation impact increased revenue by two percent and ...

New results from Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) showed once-daily, oral baricitinib 4 mg helped ...

With international enrolments under pressure and institutional budgets tightening, flexible payment models are becoming ...